Hemispherx Biopharma (HEB) Doubles Q1 Loss to 2c/Share

Hemispherx Biopharma, Inc. (NYSE: HEB) reported Q1 EPS of ($0.02), versus ($0.01) reported last year.

For earnings history and earnings-related data on Hemispherx Biopharma, Inc. (HEB) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity to acquire Harte Hanks for $5 per share in cash and stock
• Sinda Ltd. Reports Second Quarter 2026 Financial Results and Provides Operational Update